FITC Anti-Human CD56 (MEM 188)
CD56 Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2a
Reactivity
Human
Applications
FC
Conjugate
FITC Fluorescent Dye
CloneNo.
MEM 188
Cat no : FITC-65067
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | Human peripheral blood lymphocytes |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 10 µl per 10^6 cells in a 100 µl suspension or 10 µl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
FITC-65067 targets CD56 in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Immunogen | Acute myelogenous leukemia cell line KG-1 相同性解析による交差性が予測される生物種 |
Full Name | neural cell adhesion molecule 1 |
GenBank accession number | BC014205 |
Gene symbol | NCAM1 |
Gene ID (NCBI) | 4684 |
RRID | AB_2883757 |
Conjugate | FITC Fluorescent Dye |
Excitation/Emission maxima wavelengths | 494 nm / 520 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.1% sodium azide. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
Neural cell adhesion molecule 1 (NCAM1, also known as CD56) is a cell adhesion glycoprotein of the immunoglobulin (Ig) superfamily. It is a multifunction protein involved in synaptic plasticity, neurodevelopment, and neurogenesis. NCAM1 is expressed on human neurones, glial cells, skeletal muscle cells, NK cells and a subset of T cells, and the expression is observed in a wide variety human tumors, including myeloma, myeloid leukemia, neuroendocrine tumors, Wilms' tumor, neuroblastoma, and NK/T cell lymphomas.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for FITC CD56 antibody FITC-65067 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |